An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression
PHASE2CompletedINTERVENTIONAL
Enrollment
96
Participants
Timeline
Start Date
September 30, 2003
Study Completion Date
October 31, 2004
Conditions
Depressive Disorder
Interventions
DRUG
MDL100.907
Trial Locations (1)
20892
National Institute of Mental Health (NIMH), Bethesda
All Listed Sponsors
lead
National Institute of Mental Health (NIMH)
NIH
NCT00070694 - An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression | Biotech Hunter | Biotech Hunter